Brian Mueller Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Brian Mueller.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Brian Mueller. Brian Mueller is EVP, Chief Financial Officer in BIOMARIN PHARMACEUTICAL INC ($BMRN) and SVP, Acting CFO in BIOMARIN PHARMACEUTICAL INC ($BMRN) and SVP, Corporate Controller in BIOMARIN PHARMACEUTICAL INC ($BMRN) and SVP, Finance and CAO in BIOMARIN PHARMACEUTICAL INC ($BMRN) and VP, Corporate Controller in BIOMARIN PHARMACEUTICAL INC ($BMRN) and in Anthera Pharmaceuticals Inc ($ANTH).

Latest Insider Trading Transactions of Brian Mueller

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ANTH, BMRN

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 11 2021BMRNBIOMARIN PHARMACEU ...Mueller BrianEVP, Chief Financia ...Option ExerciseM28.236,709189,3950
May 11 2021BMRNBIOMARIN PHARMACEU ...Mueller BrianEVP, Chief Financia ...SellS79.506,709533,36631,35738.1 K to 31.4 K (-17.62 %)
May 11 2021BMRNBIOMARIN PHARMACEU ...Mueller BrianEVP, Chief Financia ...BuyM28.236,709189,39538,06631.4 K to 38.1 K (+21.40 %)
May 11 2021BMRNBIOMARIN PHARMACEU ...Mueller BrianEVP, Chief Financia ...GrantA62.4134121,28131,35731 K to 31.4 K (+1.10 %)
Apr 02 2021BMRNBIOMARIN PHARMACEU ...Mueller BrianEVP, Chief Financia ...SellS76.305,692434,30031,01636.7 K to 31 K (-15.51 %)
Mar 23 2021BMRNBIOMARIN PHARMACEU ...Mueller BrianEVP, Chief Financia ...Payment of ExerciseF78.5251640,51636,70837.2 K to 36.7 K (-1.39 %)
Mar 17 2021BMRNBIOMARIN PHARMACEU ...Mueller BrianEVP, Chief Financia ...Option ExerciseA78.3924,8901,951,12724,890
Mar 17 2021BMRNBIOMARIN PHARMACEU ...Mueller BrianEVP, Chief Financia ...Payment of ExerciseF77.2158244,93637,22437.8 K to 37.2 K (-1.54 %)
Mar 17 2021BMRNBIOMARIN PHARMACEU ...Mueller BrianEVP, Chief Financia ...Payment of ExerciseF78.3999477,92037,80638.8 K to 37.8 K (-2.56 %)
Mar 17 2021BMRNBIOMARIN PHARMACEU ...Mueller BrianEVP, Chief Financia ...GrantA0.0010,110038,80028.7 K to 38.8 K (+35.24 %)
Feb 04 2021BMRNBIOMARIN PHARMACEU ...Mueller BrianEVP, Chief Financia ...Payment of ExerciseF82.821,07188,70028,67329.7 K to 28.7 K (-3.60 %)
Jun 30 2020BMRNBIOMARIN PHARMACEU ...Mueller BrianEVP, Chief Financia ...Option ExerciseA122.1813,2301,616,44113,230
Jun 30 2020BMRNBIOMARIN PHARMACEU ...Mueller BrianEVP, Chief Financia ...GrantA0.004,640029,74425.1 K to 29.7 K (+18.48 %)
Jun 30 2020BMRNBIOMARIN PHARMACEU ...Mueller BrianEVP, Chief Financia ...GrantA62.5932320,21525,10424.8 K to 25.1 K (+1.30 %)
Jun 30 2020BMRNBIOMARIN PHARMACEU ...Mueller BrianEVP, Chief Financia ...Option ExerciseA122.1813,2301,616,44113,230
Jun 30 2020BMRNBIOMARIN PHARMACEU ...Mueller BrianEVP, Chief Financia ...GrantA0.004,640029,74425.1 K to 29.7 K (+18.48 %)
Jun 30 2020BMRNBIOMARIN PHARMACEU ...Mueller BrianEVP, Chief Financia ...GrantA62.5932320,21525,10424.8 K to 25.1 K (+1.30 %)
Mar 24 2020BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Acting CFOPayment of ExerciseF73.0541430,24324,78125.2 K to 24.8 K (-1.64 %)
Mar 17 2020BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Acting CFOOption ExerciseA73.829,600708,6729,600
Mar 17 2020BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Acting CFOGrantA0.006,730025,19518.5 K to 25.2 K (+36.45 %)
Mar 17 2020BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Acting CFOPayment of ExerciseF84.501,303110,10418,46519.8 K to 18.5 K (-6.59 %)
Feb 04 2020BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Acting CFOGrantA0.005,800019,76814 K to 19.8 K (+41.52 %)
Feb 04 2020BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Acting CFOGrantA62.23956013,96814 K to 14 K (+0.06 %)
Jun 07 2019BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Finance and CA ...GrantA68.7829920,56613,95913.7 K to 14 K (+2.19 %)
Apr 09 2019BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...SellS94.002,953277,58213,66016.6 K to 13.7 K (-17.78 %)
Mar 26 2019BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...Payment of ExerciseF88.0541536,54116,61317 K to 16.6 K (-2.44 %)
Mar 19 2019BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...Option ExerciseA94.539,650912,2159,650
Mar 19 2019BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...GrantA0.005,780017,02811.2 K to 17 K (+51.39 %)
Mar 19 2019BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...Payment of ExerciseF94.531,149108,61511,24812.4 K to 11.2 K (-9.27 %)
Dec 20 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...GrantA68.78221,51312,39712.4 K to 12.4 K (+0.18 %)
Jun 26 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...Option ExerciseM28.232,49170,3211,718
Jun 26 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...Option ExerciseM28.232,49170,3211,718
Jun 26 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...SellS99.502,491247,85512,37514.9 K to 12.4 K (-16.76 %)
Jun 26 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...SellS99.502,491247,85512,37514.9 K to 12.4 K (-16.76 %)
Jun 26 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...BuyM28.232,49170,32114,86612.4 K to 14.9 K (+20.13 %)
Jun 26 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...BuyM28.232,49170,32114,86612.4 K to 14.9 K (+20.13 %)
Jun 26 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...SellS99.5065465,07312,37513 K to 12.4 K (-5.02 %)
Jun 26 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...SellS99.5065465,07312,37513 K to 12.4 K (-5.02 %)
Jun 18 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...SellS94.502,021190,98513,02915.1 K to 13 K (-13.43 %)
Jun 06 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...Payment of ExerciseF92.0734631,85615,05015.4 K to 15.1 K (-2.25 %)
May 14 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...SellS89.502,450219,27515,39617.8 K to 15.4 K (-13.73 %)
May 14 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...GrantA68.7828719,74017,84617.6 K to 17.8 K (+1.63 %)
Mar 26 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...Payment of ExerciseF81.3641433,68317,55918 K to 17.6 K (-2.30 %)
Mar 20 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...Option ExerciseA83.579,120762,1589,120
Mar 20 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...GrantA0.005,710017,97312.3 K to 18 K (+46.56 %)
Mar 20 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...Payment of ExerciseF84.1034629,09912,26312.6 K to 12.3 K (-2.74 %)
Mar 20 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...Payment of ExerciseF83.5730925,82312,60912.9 K to 12.6 K (-2.39 %)
Jan 09 2018ANTHAnthera Pharmaceut ...Mueller BrianOption ExerciseA1.6584,705139,76384,705
Jan 09 2018ANTHAnthera Pharmaceut ...Mueller BrianOption ExerciseA1.6584,705139,76384,705
Jun 23 2017BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...Option ExerciseM21.512,67157,4530
Jun 23 2017BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...SellS100.002,671267,10012,88515.6 K to 12.9 K (-17.17 %)
Jun 23 2017BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...BuyM21.512,67157,45315,55612.9 K to 15.6 K (+20.73 %)
Jun 06 2017BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...Payment of ExerciseF90.7237634,11112,88513.3 K to 12.9 K (-2.84 %)
May 17 2017BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...Payment of ExerciseF91.5020718,94113,26113.5 K to 13.3 K (-1.54 %)
May 10 2017BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...Option ExerciseM21.512,60055,9262,671
May 10 2017BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...SellS93.172,600242,24213,46816.1 K to 13.5 K (-16.18 %)
May 10 2017BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...BuyM21.512,60055,92616,06813.5 K to 16.1 K (+19.31 %)
May 10 2017BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...SellS91.174,882445,09213,46818.4 K to 13.5 K (-26.60 %)
May 10 2017BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...GrantA70.3027018,98218,35018.1 K to 18.4 K (+1.49 %)
Mar 24 2017BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...Option ExerciseA87.427,740676,6317,740
Mar 24 2017BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...GrantA0.004,790018,08013.3 K to 18.1 K (+36.04 %)
Mar 17 2017BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...Payment of ExerciseF90.9637634,20113,29013.7 K to 13.3 K (-2.75 %)
Mar 17 2017BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...Payment of ExerciseF92.5033631,08013,66614 K to 13.7 K (-2.40 %)
Aug 03 2016BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...SellS100.0028728,70014,26014.5 K to 14.3 K (-1.97 %)
Jun 07 2016BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...Payment of ExerciseF90.0037633,84014,54714.9 K to 14.5 K (-2.52 %)
May 17 2016BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...Payment of ExerciseF82.7120717,12114,92315.1 K to 14.9 K (-1.37 %)
May 10 2016BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...Payment of ExerciseF80.8044435,87515,13015.6 K to 15.1 K (-2.85 %)
May 10 2016BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...GrantA51.2632716,76315,57415.2 K to 15.6 K (+2.14 %)
Apr 29 2016ANTHAnthera Pharmaceut ...Mueller BrianOption ExerciseA3.8041,379157,24041,379
Mar 17 2016BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...Option ExerciseA83.437,000584,0107,000
Mar 17 2016BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...Payment of ExerciseF80.3437630,20815,24715.6 K to 15.2 K (-2.41 %)
Mar 17 2016BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...GrantA0.003,570015,62312.1 K to 15.6 K (+29.62 %)
Dec 24 2015ANTHAnthera Pharmaceut ...Mueller BrianOption ExerciseM2.8910,00028,9002,500
Dec 24 2015ANTHAnthera Pharmaceut ...Mueller BrianBuyM2.8910,00028,90010,0000 to 10 K
Jun 08 2015BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...Payment of ExerciseF120.4652262,88011,92612.4 K to 11.9 K (-4.19 %)
Jun 03 2015BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...Payment of ExerciseF125.5730838,67612,44812.8 K to 12.4 K (-2.41 %)
May 22 2015ANTHAnthera Pharmaceut ...Mueller BrianOption ExerciseA4.7528,846137,01928,846
May 19 2015BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...Payment of ExerciseF122.7820725,41512,75613 K to 12.8 K (-1.60 %)
May 12 2015BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...Payment of ExerciseF121.6644454,01712,96313.4 K to 13 K (-3.31 %)
May 12 2015BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...GrantA51.2660731,11713,40712.8 K to 13.4 K (+4.74 %)
Mar 17 2015BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...Option ExerciseA124.379,0001,119,3309,000
Mar 17 2015BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...GrantA0.004,000012,8008.8 K to 12.8 K (+45.45 %)
Mar 05 2015BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...Option ExerciseM28.237,000197,6107,491
Mar 05 2015BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...SellS109.467,000766,2108,80015.8 K to 8.8 K (-44.30 %)
Mar 05 2015BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...BuyM28.237,000197,61015,8008.8 K to 15.8 K (+79.55 %)
Mar 05 2015BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...Option ExerciseA63.1010,000631,00010,000
Mar 05 2015BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...GrantA0.004,00008,8004.8 K to 8.8 K (+83.33 %)

Page:   1

Contact us | Follow us on Twitter